Back

Cardiovascular benefits of GLP-1 (liraglutide) treatment in experimental arterial hypertension are mediated by the endothelial GLP-1 receptor

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Risk factors for cardiovascular disease Leukocytes, Inflammation, Immunity ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Sebastian Steven

University Medical Center of Mainz, Mainz (Germany)

12 More presentations in this session

Presentation thumbnail
Doctor E. Solomou (Athens, GR)
Abstract
Presentation thumbnail
Doctor N. Bonetti (Zurich, CH)
Abstract
Presentation thumbnail
Doctor M. Soerensen (Slagelse, DK)
Abstract Slides
Presentation thumbnail
Doctor Y. Yamase (Tajimi, JP)
Abstract
Presentation thumbnail
Associate Professor M. Rahman (Bogra, BD)

Access the full session

Session thumbnail
Poster Session 5 - Risk factors for cardiovascular disease

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET